Cohort studyindependent cross-checkfull text checked★ key study I-ABX-07 in-depth review

Faster antibiotics in sepsis save lives

Time to Treatment and Mortality during Mandated Emergency Care for Sepsis.

Overview

Seymour CW et al.. N Engl J Med 2017 · PMID 28528569 · DOI 10.1056/NEJMoa1703058

Each hour of delay in antibiotics was linked to about 4% higher odds of death.

Does the study support the specific claim? No · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Assess timing.

How was the study done?

Cohort.

How many people, animals or samples were studied?

49,331 sepsis patients in 149 New York hospitals (2014-2016).

What was actually found?

Each hour of delay to antibiotics was linked to 4% higher odds of dying in hospital; delay from 1 to 6 hours to complete the bundle meant about 3 percentage points more deaths. Faster IV fluids showed no clear effect.

How large was the observed effect?

OR 1.04 per hour.

What do the results mean in everyday life?

Antibiotics are vital in sepsis.

What are the study's limitations?

Observational; antibiotic appropriateness unknown; one US state.

What does it say about Elawady's specific claim?

Contradicts 'never antibiotics'.

Do the results apply to Germany and Europe?

High.

What can explicitly not be concluded from this study?

Exact causal size of benefit per hour; applies to sepsis, not to minor infections.

Scientific in-depth review

1. Full reference

Authors
Seymour CW et al.
Journal
N Engl J Med
Year
2017
Identifier
PMID 28528569 DOI 10.1056/NEJMoa1703058
Verification
verified – PubMed efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
full text
Conflicts of interest and funding

Supported by NIH grants R35GM119519 and K08 GM115859, VA HSR&D grant 11-109 13-079, and IPRO; author disclosure forms at NEJM.org (not in text).

2. Research question

Is faster sepsis treatment associated with lower mortality?

3. Study design and population

Study design
Cohort study – Retrospective observational cohort of state-mandated sepsis protocols (New York State Department of Health database), multilevel risk-adjusted logistic models
Population

Adults (>17 years) with severe sepsis or septic shock (Sepsis-2 criteria) and sepsis protocol initiated in the emergency department within 6 h of arrival, in 149 New York hospitals (median age 73)

Country

USA (New York)

Period

1 April 2014 to 30 June 2016

Sample size

49,331 patients at 149 hospitals (from 111,816 at 185 hospitals); 26,978 in fluid-bolus analysis

Inclusion and exclusion criteria

Included: protocol initiated in ED within 6 h; 3-hour bundle completed within 12 h. Excluded: ineligible (18.8%), protocol outside ED (29.2%), after 6 h (3.3%), bundle >12 h (4.6%), contraindication, treatment-limiting advance directives, refusal, trial enrolment; hospitals with <50 cases

4. Methods and endpoints

Exposure / intervention

Time (hours) from protocol initiation to completion of 3-hour bundle (blood culture, broad-spectrum antibiotics, lactate), to antibiotic administration, and to completion of 30 ml/kg fluid bolus

Comparator

Per-hour delay; completion within 3 h vs 3-12 h

Endpoints

Risk-adjusted in-hospital mortality

Statistical methods

Multilevel logistic regression with hospital random effects, a-priori covariates (demographics, comorbidities, infection site, admission source, shock, lactate, platelets, ventilation); internally validated risk model; sensitivity analyses; quantitative bias analysis for unmeasured confounding

5. Actual results

Results

82.5% had bundle completed within 3 h; median times: bundle 1.30 h (IQR 0.65-2.35), antibiotics 0.95 h (0.35-1.95), fluid bolus 2.56 h (1.33-4.20). In-hospital mortality 22.8% overall. Per hour to bundle completion OR 1.04 (95% CI 1.02-1.05); bundle in 3-12 h vs <=3 h OR 1.14 (1.07-1.21). Per hour to antibiotics OR 1.04 (1.03-1.06); antibiotics in 3-12 h vs <=3 h OR 1.14 (1.06-1.22). Associations stronger in patients receiving vasopressors. Fluid bolus per hour OR 1.01 (0.99-1.02; P=0.21). Bias analysis: results robust unless an unmeasured confounder were at least twice as prevalent with later treatment and raised odds of death by >1.35.

Absolute risks

Bundle completion at 6 h vs within the first hour associated with approximately 3 percentage points higher in-hospital mortality (predicted, typical patient); crude in-hospital mortality 22.6% (bundle <=3 h) vs 23.6% (3-12 h)

Authors' conclusion

Longer time to completion of the 3-hour bundle and to antibiotics was associated with higher risk-adjusted in-hospital mortality; time to fluid bolus was not; if causal, faster recognition and treatment could reduce avoidable deaths.

6. Strengths

  • Large mandated statewide dataset with audits (>98% of audited cases confirmed sepsis)
  • Pre-specified covariates and validated risk model
  • Multiple sensitivity analyses and quantitative bias analysis
  • Dose-response by hour

7. Weaknesses

  • Not randomised; residual confounding (e.g. diagnostic difficulty delaying treatment)
  • Appropriateness of antibiotic choice not known
  • One US state; Sepsis-2 definitions
  • Patients with bundle >12 h excluded; time-zero inaccuracies possible
  • Per-hour effect small (4% odds increase)

8. Risk of bias

Orienting tool
ROBINS-I
Type of assessment
structured assessment based on the full text by a single reviewer (no formal double review)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Single-reviewer structured ROBINS-I-oriented judgement based on the full text ('some_concerns' corresponds to ROBINS-I 'moderate'); not formal (needs two independent reviewers and a protocol).

8. Risk of bias
DomainJudgementRationale
Confoundingsome concernsExtensive risk adjustment and bias analysis, but atypical presentations may both delay treatment and raise mortality.
Selection of participantssome concernsRestriction to ED protocols within 6 h and bundle within 12 h; excludes very delayed or hospital-onset cases.
Classification of interventionssome concernsTime stamps from case-report forms; protocol start may not equal recognition time (sensitivity analysis from ED arrival similar).
Deviations from intended interventionsnot applicableExposure is observed timing.
Missing datalowMandated reporting with audits.
Measurement of outcomeslowIn-hospital death objective; hospice reclassification did not change results.
Selection of reported resultlowPrimary exposure and outcome pre-specified; sensitivity analyses reported.

Full-text review (25 October 2026): Added inclusion/exclusion flow (111,816 to 49,331), median treatment times, overall mortality 22.8%, 3-12 h vs <=3 h ORs, absolute difference (~3 percentage points), bias analysis, funding; ROBINS-I domains (overall unchanged).

9. Assessment of the statistical interpretation

Small per-hour relative effects (OR 1.04) on a high baseline mortality (about 23%) translate into an estimated ~3 percentage-point higher mortality when bundle completion is delayed from 1 to 6 hours; association, not proven causation.

10. Relevance to the specific claim

Contradicts C-ABX-12.

11. Independent contrary findings

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Strong observational evidence that delayed antibiotics in sepsis are associated with higher mortality; directly contradicts a blanket refusal of antibiotics in serious infection.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biassome concerns
Precision of resultshigh
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

15. Linked fact checks